Literature DB >> 26145280

Short-term effects of Poly(I:C) on gut permeability.

Valentina Moyano-Porcile1, Loreto Olavarría-Ramírez1, Camila González-Arancibia1, Javier A Bravo1, Marcela Julio-Pieper2.   

Abstract

The intestinal barrier function depends on an adequate response to pathogens by the epithelium. Toll-like receptor 3 (TLR-3) recognizes double-stranded RNA, a virus-associated molecular pattern. Activation of TLR-3 with Poly(I:C), a synthetic agonist, modulates tissue repair and permeability in other epithelia; however, the effects of local luminal TLR-3 agonists on gut barrier function are unknown. The aim of this investigation was to evaluate short-term effects of Poly(I:C) on rat ileal and colonic permeability ex vivo. We also studied the acute effects of intrarectal administration of Poly(I:C) on colonic barrier function. Ileum tissues displayed decreased transepithelial electrical resistance (TEER) 1h after incubation with 200μg/mL Poly(I:C); however, the mucosa-to-serosa transit of macromolecules (4.4 and 40kDa dextrans - TD4.4 and FD40, respectively) remained unchanged. Conversely, colon tissue preparations stimulated with 200μg/mL Poly(I:C) showed a decreased thinning of the mucosal layer after 2h and a decreased transit of FD40 after 3h, in comparison to controls. There was no change in colonic TEER after 3h of treatment. In addition, colon tissue taken from rats 6h after an intrarectal administration of 100μg Poly(I:C) also showed decreased permeability to FD40 in the everted gut sac assay at 3h post-extraction. Tissue morphology remained unchanged. Our results suggest that an acute exposure to Poly(I:C) reduces colon permeability to macromolecules but increases ileum permeability to electrolytes/small molecules ex vivo. Although the mechanism associated to these effects needs further investigation, to our knowledge this is the first report of a direct effect of a TLR-3 ligand in intestinal barrier function and may be of significance to understand region-specific interactions between gut mucosa and microbiota.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Intestinal barrier; Intestinal permeability; Poly(I:C); Polyinosinic–polycytidylic acid (PubChem CID: 32744); TLR-3

Mesh:

Substances:

Year:  2015        PMID: 26145280     DOI: 10.1016/j.phrs.2015.06.016

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  6 in total

1.  Effect of toll-like receptor 3 agonist poly I:C on intestinal mucosa and epithelial barrier function in mouse models of acute colitis.

Authors:  Hong-Wei Zhao; Yue-Hong Yue; Hua Han; Xiu-Li Chen; Yong-Gang Lu; Ji-Min Zheng; Hong-Tao Hou; Xiao-Meng Lang; Li-Li He; Qi-Lu Hu; Zi-Qian Dun
Journal:  World J Gastroenterol       Date:  2017-02-14       Impact factor: 5.742

2.  Investigating Gut Permeability in Animal Models of Disease.

Authors:  Marianela González-González; Camilo Díaz-Zepeda; Johana Eyzaguirre-Velásquez; Camila González-Arancibia; Javier A Bravo; Marcela Julio-Pieper
Journal:  Front Physiol       Date:  2019-01-15       Impact factor: 4.566

Review 3.  Gut Susceptibility to Viral Invasion: Contributing Roles of Diet, Microbiota and Enteric Nervous System to Mucosal Barrier Preservation.

Authors:  Marcela Julio-Pieper; Alejandra López-Aguilera; Johana Eyzaguirre-Velásquez; Loreto Olavarría-Ramírez; Claudia Ibacache-Quiroga; Javier A Bravo; Gonzalo Cruz
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

Review 4.  The Pivotal Role of Microbiota in Modulating the Neuronal-Glial-Epithelial Unit.

Authors:  Siyu Luo; Huifeng Zhu; Junhui Zhang; Dong Wan
Journal:  Infect Drug Resist       Date:  2021-12-21       Impact factor: 4.003

Review 5.  Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders.

Authors:  John R Kelly; Paul J Kennedy; John F Cryan; Timothy G Dinan; Gerard Clarke; Niall P Hyland
Journal:  Front Cell Neurosci       Date:  2015-10-14       Impact factor: 5.505

6.  Sertraline and Citalopram Actions on Gut Barrier Function.

Authors:  Johana Eyzaguirre-Velásquez; María Paz González-Toro; Camila González-Arancibia; Jorge Escobar-Luna; Caroll J Beltrán; Javier A Bravo; Marcela Julio-Pieper
Journal:  Dig Dis Sci       Date:  2020-11-12       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.